Administration of 4-(α-L-Rhamnosyloxy)-benzyl isothiocyanate delays disease phenotype in SOD1G93A Rats: A transgenic model of amyotrophic lateral sclerosis

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Galuppo, Maria ^a   Giacoppo, Sabrina ^a   Iori, Renato ^b   De Nicola, Gina Rosalinda ^b   Bramanti, Placido ^a   Mazzon, Emanuela ^a  

^a IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

^b ISTITUTO NAZIONALE DELLA NUTRIZIONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 (ALPHA RHAMNOSYLOXY) BENZYL ISOTHIOCYANATE; BENZYL ISOTHIOCYANATE; THIOGLUCOSIDASE; UNCLASSIFIED DRUG; 4-((ALPHA-L-RHAMNOSYLOXY)BENZYL)ISOTHIOCYANATE; GLYCOSIDASE; ISOTHIOCYANIC ACID DERIVATIVE; MUTANT PROTEIN; RHAMNOSE; SOD1 G93A PROTEIN; SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; MALE; NONHUMAN; PHENOTYPE; RAT; TRANSGENIC RAT; ANALOGS AND DERIVATIVES; ANIMAL; BIOTRANSFORMATION; BRAIN; DISEASE MODEL; DRUG EFFECTS; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

MORINGA OLEIFERA; RATTUS;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; BIOTRANSFORMATION; BRAIN; DISEASE MODELS, ANIMAL; GLYCOSIDE HYDROLASES; HUMANS; ISOTHIOCYANATES; MALE; MUTANT PROTEINS; PHENOTYPE; RATS; RATS, SPRAGUE-DAWLEY; RATS, TRANSGENIC; RHAMNOSE; SUPEROXIDE DISMUTASE;

EID: 84929643640     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/259417     Document Type: Article

References (30)

1. Y. Doi, N. Atsuta, G. Sobue, M. Morita, and I. Nakano, "Prevalence and incidence of amyotrophic lateral sclerosis in Japan, " Journal of Epidemiology, vol. 24, no. 6, pp. 494-499, 2014.
2. A. Malaspina, F. Puentes, and S. Amor, "Disease origin and progression in amyotrophic lateral sclerosis: an immunology perspective, " International Immunology, vol. 27, no. 3, pp. 117-129, 2015.
3. J. Rafaowska, D. Sulejczak, S. J. Chrapusta, R. Gadamski, and D. Dziewulska, "Diverse expression of selected SMN complex proteins in humans with sporadic amyotrophic lateral sclerosis and in a transgenic rat model of familial form of the disease, " PLoS ONE, vol. 9, no. 8, Article ID e104614, 2014.
4. A. Eisen, "Amyotrophic lateral sclerosis is a multifactorial disease, " Muscle and Nerve, vol. 18, no. 7, pp. 741-752, 1995.
5. R. Gunther, K. A. Saal, M. Suhr et al., "The rho kinase inhibitor Y-27632 improves motor performance in male SOD1(G93A) mice, " Frontiers inNeuroscience, vol. 8, article 304, 9 pages, 2014.
6. M. Benatar, "Lost in translation: treatment trials in the SOD1 mouse and in human ALS, " Neurobiology of Disease, vol. 26, no. 1, pp. 1-13, 2007.
7. A. Stewart, J. Sandercock, S. Bryan et al., "The clinical effectiveness and cost-effectiveness of riluzole for motor neurone disease: a rapid and systematic review, " Health Technology Assessment, vol. 5, no. 2, pp. 1-97, 2001.
8. B. Halliwell, "Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment, " Drugs & Aging, vol. 18, no. 9, pp. 685-716, 2001.
9. Y. Li, R. Sattler, E. J. Yang et al., "Harmine, a natural beta-carboline alkaloid, upregulates astroglial glutamate transporter expression, " Neuropharmacology, vol. 60, no. 7-8, pp. 1168-1175, 2011.
10. D. Gueyrard, J. Barillari, R. Iori, S. Palmieri, and P. Rollin, "First synthesis of anO-glycosylated glucosinolate isolated from Moringa oleifera, " Tetrahedron Letters, vol. 41, no. 43, pp. 8307-8309, 2000.
11. D. Gueyrard, J. Barillari, R. Iori, S. Palmieri, and P. Rollin, "Isolation and synthesis of 4-rhamno-glucosinalbin, the major glucosinolate from Moringa oleifera, " in Natural Products in the New Millennium: Prospects and Industrial Application, A. P. Rauter, M. E. Araújo, F. B. Palma, J. Justino, and S. P. Santos, Eds., vol. 47 of Proceedings of the Phytochemical Society of Europe, pp. 415-419, Springer, Dordrecht, The Netherlands, 2002.
12. R. N. Bennett, F. A. Mellon, N. Foidl et al., "Profiling glucosinolates and phenolics in vegetative and reproductive tissues of the multi-purpose trees Moringa oleifera L. (Horseradish tree) and Moringa stenopetala L., " Journal of Agricultural and Food Chemistry, vol. 51, no. 12, pp. 3546-3553, 2003.
13. D. Brunelli, M. Tavecchio, C. Falcioni et al., "Theisothiocyanate produced from glucomoringin inhibits NF-kB and reduces myeloma growth in nude mice in vivo, " Biochemical Pharmacology, vol. 79, no. 8, pp. 1141-1148, 2010.
14. M. Maldini, S. A. Maksoud, F. Natella et al., "Moringa oleifera: study of phenolics and glucosinolates by mass spectrometry, " Journal of Mass Spectrometry, vol. 49, no. 9, pp. 900-910, 2014.
15. B. Padayachee and H. Baijnath, "An overview of the medicinal importance of Moringaceae, " Journal of Medicinal Plants Research, vol. 6, no. 48, pp. 5831-5839, 2012.
16. S. Giacoppo, M. Galuppo, G. R. De Nicola, R. Iori, P. Bramanti, and E. Mazzon, "4(-l-Rhamnosyloxy)-benzyl isothiocyanate, a bioactive phytochemical that attenuates secondary damage in an experimental model of spinal cord injury, " Bioorganic & Medicinal Chemistry, vol. 23, no. 1, pp. 80-88, 2015.
17. M. Galuppo, S. Giacoppo, G. R. DeNicola et al., "Antiinflammatory activity of glucomoringin isothiocyanate in a mousemodel of experimental autoimmune encephalomyelitis, " Fitoterapia, vol. 95, pp. 160-174, 2014.
18. EEC, "Oilseeds-determination of glucosinolates high performance liquid chromatography, " Official Journal of European Community L, vol. 170, pp. 27-34, 1990, European Economic Community, Commission Regulation, EEC No. 1864/90.
19. A. Pessina, R. M. Thomas, S. Palmieri, and P. L. Luisi, "An improved method for the purification of myrosinase and its physicochemical characterization, " Archives of Biochemistry and Biophysics, vol. 280, no. 2, pp. 383-389, 1990.
20. J. Feng, Z. Yan, A. Ferreira et al., "Spinophilin regulates the formation and function of dendritic spines, " Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 16, pp. 9287-9292, 2000.
21. P. Morazzoni, C. Manzotti, G. Fontana, A. Riva, and R. Iori, "Use of isothiocyanate derivatives as anti-myeloma agents, " Patent no. US 8772251 B2, 2014.
22. C. Waterman, D. M. Cheng, P. Rojas-Silva et al., "Stable, water extractable isothiocyanates fromMoringa oleifera leaves attenuate inflammation in vitro, " Phytochemistry, vol. 103, pp. 114-122, 2014.
23. M. Sta, R. M. R. Sylva-Steenland, M. Casula et al., "Innate and adaptive immunity in amyotrophic lateral sclerosis: evidence of complement activation, " Neurobiology of Disease, vol. 42, no. 3, pp. 211-220, 2011.
24. B. N. Dittel, "CD4 T cells: balancing the coming and going of autoimmune-mediated inflammation in the CNS, " Brain, Behavior, and Immunity, vol. 22, no. 4, pp. 421-430, 2008.
25. C.-A. Lewis, J. Manning, F. Rossi, and C. Krieger, "The neuroinflammatory response in ALS: the roles of microglia and T cells, " Neurology Research International, vol. 2012, Article ID803701, 8 pages, 2012.
26. J. H. Shin, Y. A. Lee, J. K. Lee et al., "Concurrent blockade of free radical and microsomal prostaglandin E synthase-1-mediated PGE2 production improves safety and efficacy in amousemodel of amyotrophic lateral sclerosis, " Journal of Neurochemistry, vol. 122, no. 5, pp. 952-961, 2012.
27. J. Izecka and Z. Stelmasiak, "Creatine kinase activity in amyotrophic lateral sclerosis patients, " Neurological Sciences, vol. 24, no. 4, pp. 286-287, 2003.
28. M. Ukaszewicz-Zajc, B. Mroczko, and A. Sowik, "Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in amyotrophic lateral sclerosis (ALS), " Journal of Neural Transmission, vol. 121, no. 11, pp. 1387-1397, 2014.
29. S. H. Kim, J. I. Engelhardt, J. S. Henkel et al., "Widespread increased expression of the DNA repair enzyme PARP in brain in ALS, " Neurology, vol. 62, no. 2, pp. 319-322, 2004.
30. M. Galuppo, G. R. De Nicola, R. Iori, P. Dell'Utri, P. Bramanti, and E. Mazzon, "Antibacterial activity of glucomoringin bioactivated with myrosinase against two important pathogens affecting the health of long-term patients in hospitals, " Molecules, vol. 18, no. 11, pp. 14340-14348, 2013.